SweetgreenNYSE: SG

Cava, Hims & Hers Health, and Sweetgreen have more than doubled in 2024. Cava and Sweetgreen should continue to benefit from the return to in-office workplaces.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

In the latest trading session, Sweetgreen, Inc. (SG) closed at $32.60, marking a +0.9% move from the previous day.

Sweetgreen CEO Jonathan Neman joins CNBC's 'The Exchange' to discuss how menu expansion has helped drive Sweetgreen's profitability, where the company is opening automated locations, and more.

Sweetgreen put up better-than-expected growth numbers in the first quarter. It also raised its guidance for the full year.

Sweetgreen, Inc. (SG) closed the most recent trading day at $30.82, moving +0.23% from the previous trading session.

Sweetgreen Inc., a fast casual restaurant chain, saw its shares surge by 34% following the release of its Q1 2024 earnings report. Despite reporting a loss that was 5 cents higher than expected, the stock price rose unexpectedly, leaving some investors surprised.

Sweetgreen stock recently skyrocketed after showing improvement in its restaurant-level profitability. Investors are optimistic that its improvements can continue, but the company is still reporting steep net losses.

Sweetgreen's growth strategies, including Sweetpass and menu innovations, have gained positive traction and are expected to drive further growth. The launch of Sweetpass has provided SG with direct access to consumers' phones, allowing for targeted marketing and data collection. Menu innovation, such as the introduction of Protein Plates, has helped SG capture a larger share of consumers' daypart meal budget and diversify its revenue stream.